Trials / Completed
CompletedNCT02626871
Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 850 (actual)
- Sponsor
- University of Turku · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.
Conditions
Timeline
- Start date
- 2002-01-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-12-10
- Last updated
- 2017-05-04
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT02626871. Inclusion in this directory is not an endorsement.